Kamal Abu Jabal
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 07, 2025
Optimizing the schedule of BNT162b2 COVID-19 against long COVID and associated quality of life losses.Paul Kuodi, Haneen Shibli, Hiba Zayyad
|Jan 25, 2023
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022.Yanay Gorelik, Amiel Dror, Hiba Zayyad
|Aug 26, 2022
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel.Paul Kuodi, Yanay Gorelik, Hiba Zayyad
|Aug 12, 2022
Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel.Yair Blumberg, Michael Edelstein, Kamal Abu Jabal
|Aug 17, 2021
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti
Pageof 1
